LISA MICIK: Open Payments
NPI 1003826157 · PARAMUS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,244 in 113 payments from 20 companies in 2025. Trend: 2023 $978 · 2024 $1,285 · 2025 $2,244
Food & beverage: $2,155Travel & lodging: $89
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $587 |
| Galderma Laboratories, L.P. | 17 | $351 |
| Amgen Inc. | 7 | $224 |
| Arcutis Biotherapeutics, Inc. | 12 | $165 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 14 | $144 |
| Botanix SB Inc | 11 | $143 |
| Journey Medical Corporation | 1 | $122 |
| Novartis Pharmaceuticals Corporation | 5 | $113 |
| UCB, Inc. | 4 | $72 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $53 |
Products named: BOTOX, NEMLUVIO, OTEZLA, SKYRIZI, Zoryve, SOFDRA, EMROSI, COSENTYX.
Industry payments across NJ — which companies pay providers there.
